Search

Author/Creator Provencio, M.

12. Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group. (September 2020)

Authors:
Remon, J.; Nadal, E.; Dómine, M.; Ruffinelli, J.; García, Y.; Pardo, J.C.; López, R.; Cilleruelo, A.; García-Campelo, R.; Martín, P.; Juan, O.; González-Larriba, J.L.; Provencio, M.; Olmedo, E.; Ponce, S.; Cumplido, D.; Barenys, C.; Majem, M.; Massutti, B.; Rodriguez-Abreu, D.
Journal:
Lung cancer
Issue:
Volume 147(2020)
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL) AFTER AUTOLOGOUS TRANSPLANTATION: 5‐YEAR OVERALL SURVIVAL FROM THE PHASE 2 CHECKMATE 205 STUDY. (17th June 2021)

Authors:
Ansell, S. M.; Bröckelmann, P. J.; von Keudell, G.; Lee, H. J.; Santoro, A.; Zinzani, P. L.; Collins, G. P.; Cohen, J. B.; De Boer, J. P.; Kuruvilla, J.; Savage, K. J.; Trneny, M.; Provencio, M.; Jaeger, U.; Willenbacher, W.; Swanink, R.; Sacchi, M.; Shipp, M. A.; Engert, A.; Armand, P.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 205 COHORT D 2‐YEAR FOLLOW‐UP. (12th June 2019)

Authors:
Ansell, S.; Ramchandren, R.; Domingo‐Domènech, E.; Rueda, A.; Trněný, M.; Feldman, T.; Lee, H.; Provencio, M.; Sillaber, C.; Cohen, J.; Savage, K.; Willenbacher, W.; Sumbul, A.; Sacchi, M.; Armand, P.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
146
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study. Issue 3 (June 2015)

Authors:
Esteban, E.; Majem, M.; Martinez Aguillo, M.; Martinez Banaclocha, N.; Dómine, M.; Gómez Aldaravi, L.; Juan, O.; Cajal, R.; Gonzalez Arenas, M.C.; Provencio, M.
Journal:
Cancer epidemiology
Issue:
Volume 39:Issue 3(2015)
Page Start:
291
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. S205: ZANUBRUTINIB + OBINUTUZUMAB (ZO) VS OBINUTUZUMAB (O) MONOTHERAPY IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PRIMARY ANALYSIS OF THE PHASE 2 RANDOMIZED ROSEWOOD TRIAL. (23rd June 2022)

Authors:
Zinzani, P. L.; Mayer, J.; Auer, R.; Bijou, F.; de Oliveira, A. C.; Flowers, C. R.; Merli, M.; Bouabdallah, K.; Ganly, P. S.; Song, Y.; Zhang, H.; Johnson, R.; García-Sancho, A. M; Provencio, M.; Trněný, M.; Yuen, S.; Tilly, H.; Kingsley, E.; Tuyman, G.; Assouline, S. E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
106
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

17. SAFETY ANALYSIS OF PATIENTS WITH A MEDICAL HISTORY OF RESPIRATORY DISORDERS TREATED WITH COPANLISIB FROM THE CHRONOS‐1 STUDY IN RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA. (12th June 2019)

Authors:
Zinzani, P.L.; Santoro, A.; Leppä, S.; Demeter, J.; Follows, G.A.; Lenz, G.; Kim, W.S.; Mollica, L.; Nagler, A.; Phipps Diong, C.; Provencio, M.; Magagnoli, M.; Munoz, J.; Miriyala, A.; Liu, L.; Zhang, M.; Garcia‐Vargas, J.; Childs, B.H.; Dreyling, M.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗